{"entity":{"type":"insider","cik":"0001341642","url":"/insider/0001341642","json_url":"/insider/0001341642.json","name":"Mack David Henry","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":5,"first":"2011-02-18","last":"2025-07-03","span_basis":"filed_date"},"name_variants":[{"name":"Mack David Henry","source":"filing","n_filings":5,"first_seen":"2011-02-18","last_seen":"2025-07-03"}],"transactions":[{"id":4467389,"accession":"0001415889-25-019380","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-019380","line_url":"/filing/0001415889-25-019380#line-1","is_derivative":false,"issuer_cik":"0001341642","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001341642","owner_cik":"0001341642","owner_name":"Mack David Henry","owner_display_name":"Mack David Henry","owner_url":"/insider/0001341642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58411.0,"shares_display":"58,411","price_per_share":1.0645,"price_display":"1.06","price_state":"stated","total_value":62178.5095,"total_display":"62,178.51","total_whole":"62,179","shares_owned_after":536133.0,"shares_owned_after_display":"536,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-03","scope":"insider"},{"id":5162693,"accession":"0001209191-21-047745","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-047745","line_url":"/filing/0001209191-21-047745#line-4","is_derivative":false,"issuer_cik":"0001341642","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001341642","owner_cik":"0001341642","owner_name":"Mack David Henry","owner_display_name":"Mack David Henry","owner_url":"/insider/0001341642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26767.0,"shares_display":"26,767","price_per_share":35.7564,"price_display":"35.76","price_state":"stated","total_value":957091.5588,"total_display":"957,091.56","total_whole":"957,092","shares_owned_after":12470.0,"shares_owned_after_display":"12,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-22","scope":"insider"},{"id":5162687,"accession":"0001209191-21-047745","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-047745","line_url":"/filing/0001209191-21-047745#line-2","is_derivative":false,"issuer_cik":"0001341642","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001341642","owner_cik":"0001341642","owner_name":"Mack David Henry","owner_display_name":"Mack David Henry","owner_url":"/insider/0001341642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1029.0,"shares_display":"1,029","price_per_share":35.53,"price_display":"35.53","price_state":"stated","total_value":36560.37,"total_display":"36,560.37","total_whole":"36,560","shares_owned_after":12470.0,"shares_owned_after_display":"12,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-22","scope":"insider"},{"id":5293075,"accession":"0001209191-21-043738","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-043738","line_url":"/filing/0001209191-21-043738#line-2","is_derivative":false,"issuer_cik":"0001341642","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001341642","owner_cik":"0001341642","owner_name":"Mack David Henry","owner_display_name":"Mack David Henry","owner_url":"/insider/0001341642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":204.0,"shares_display":"204","price_per_share":35.53,"price_display":"35.53","price_state":"stated","total_value":7248.12,"total_display":"7,248.12","total_whole":"7,248","shares_owned_after":12470.0,"shares_owned_after_display":"12,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"},{"id":4376753,"accession":"0001209191-21-035364","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-035364","line_url":"/filing/0001209191-21-035364#line-4","is_derivative":false,"issuer_cik":"0001341642","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001341642","owner_cik":"0001341642","owner_name":"Mack David Henry","owner_display_name":"Mack David Henry","owner_url":"/insider/0001341642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6207.0,"shares_display":"6,207","price_per_share":35.7083,"price_display":"35.71","price_state":"stated","total_value":221641.4181,"total_display":"221,641.42","total_whole":"221,641","shares_owned_after":2470.0,"shares_owned_after_display":"2,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-21","filed_date":"2021-05-24","scope":"insider"},{"id":4376748,"accession":"0001209191-21-035364","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-035364","line_url":"/filing/0001209191-21-035364#line-2","is_derivative":false,"issuer_cik":"0001341642","issuer_name":"PMV Pharmaceuticals, Inc.","issuer_ticker":"PMVP","issuer_name_source":null,"issuer_url":"/issuer/0001341642","owner_cik":"0001341642","owner_name":"Mack David Henry","owner_display_name":"Mack David Henry","owner_url":"/insider/0001341642","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7793.0,"shares_display":"7,793","price_per_share":35.6031,"price_display":"35.60","price_state":"stated","total_value":277454.9583,"total_display":"277,454.96","total_whole":"277,455","shares_owned_after":2470.0,"shares_owned_after_display":"2,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-20","filed_date":"2021-05-24","scope":"insider"},{"id":9142290,"accession":"0001209191-11-011322","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-11-011322","line_url":"/filing/0001209191-11-011322#line-6","is_derivative":false,"issuer_cik":"0001198323","issuer_name":"ACELRX PHARMACEUTICALS INC","issuer_ticker":"ACRX","issuer_name_source":null,"issuer_url":"/issuer/0001198323","owner_cik":null,"owner_name":"JANNEY DANIEL; ACP IV, L.P.; NOHRA GUY P; ACMP IV LLC; DELEAGE JEAN; Mack David Henry","owner_display_name":"JANNEY DANIEL","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":680000.0,"shares_display":"680,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":3400000.0,"total_display":"3,400,000.00","total_whole":"3,400,000","shares_owned_after":2794907.0,"shares_owned_after_display":"2,794,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-16","filed_date":"2011-02-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001699382","name":"PMV Pharmaceuticals, Inc.","url":"/issuer/0001699382","role":"Director, Officer (President and CEO)","n_filings":4,"first_seen":"2021-05-24","last_seen":"2025-07-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001427925","name":"ACELRX PHARMACEUTICALS INC","url":"/issuer/0001427925","role":"Ten percent owner","n_filings":1,"first_seen":"2011-02-18","last_seen":"2011-02-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001341642","retrieved_at":"2026-08-27T04:59:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}